Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-09-06
2005-09-06
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S070140, C435S006120
Reexamination Certificate
active
06939846
ABSTRACT:
The present invention is directed to a treatment for animal pruritis. One aspect of this invention involves a treatment for animal pruritis comprising one or more polypeptides with an amino acid sequence KPV (SEQ ID NO:1), VPK-AC-CC-AC-KPV, HFRWGKPV (SEQ ID NO:3), SYSMEHFRWGKPV (SEQ ID NO:4) for animal pruritis caused by exposure to any number of agents or causes. The polypeptides are at a level to effectively treat the animal pruritis and are combined with a shampoo. Other combinations include the polypeptides at a level to effectively treat animal pruritis combined with a shampoo and an antibiotic, antifungal and/or and anti-inflammatory. The one or more polypeptides can also be a dimer formed from any of the amino acid sequence above.
REFERENCES:
patent: 5028592 (1991-07-01), Lipton
patent: 5157023 (1992-10-01), Lipton
patent: 5739111 (1998-04-01), Mahe
patent: 5972962 (1999-10-01), Belfield et al.
patent: 6001812 (1999-12-01), Mahe
patent: 2003/0113284 (2003-06-01), Dalko et al.
patent: 0972 522 (2000-01-01), None
patent: 2784028 (2000-04-01), None
patent: WO 93/01211 (1993-01-01), None
patent: WO/97/10838 (1997-03-01), None
patent: WO/99/58101 (1999-11-01), None
patent: PCT/US00/07846 (2000-03-01), None
patent: WO00/42856 (2000-07-01), None
patent: WO 00/56353 (2000-09-01), None
patent: WO 00/59527 (2000-10-01), None
Capsoni, F., Meroni, P.L., Zocchi, M.R., Plebani, A.M., Vezio, M.,Effect of Corticosteroids on Neutrophil Function: Inhibition of Antibody-dependent Cell-mediated Cytotoxicity(ADCC), J. Immunopharmacol. 5, 217-230 (1983).
Catania, A., Airaghi, L., Garofalo, L., Cutuli, M., Lipton, J.M.,The Neuropeptide α-MSH in HIV Infection and Other Disorders in Humans,Ann. N.Y. Acad. Sci. 840, 848-856 (1998).
Catania, A., Lipton J.M.,α-Melanocyte Stimulating Hormone in the Modulation of Host Reactions,14 Endocr. Rev., 564-576 (1993).
Cutuli, Cristiani, Lipton and Catania,Antimicrobial effects of α-MSH peptides,Journal of Leukocyte Biology, vol. 67, Feb. 2000.
Deeter, L.B., et al.,Antipyretic Properties of Centrally Administered α-MSH Fragments in the Rabbit,Peptides 9, 1285-8 (1989).
Delgado, R., Carlin, A., Alraghi, L., Demitri, M., Meda, L., Galimberti, D., Pierluigi, B., Lipton, J.M., Catania, A.,Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia,63 J. of Leukocyte Biol. 740 (1998).
Elberle, A. N.,The Melanotropins,Karger, Basel, Switzerland (1988).
Gow, N.A.,Germ Tube Growth of Candida albicans,Curr. Topics Med. Mycol. 8, 43-45 (1997).
Hiltz, M.E., Lipton, J.M.,Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide α-MSH,3 FASEB J., 2282-2284 (1989).
Hiltz, M.E.,Anti-inflammatory Activity of α-MSH(11-13)Analogs: Influences of Alteration in Stereochemistry,Peptides 12, 767-71 (1991).
Holdeman, M., et al.,Antipyretic Activity of a Potent α-MSH Analog,Peptides 6, 273-5 (1985).
Lipton, J.M., Ceriani, G., Macaluso, A., McCoy, D., Carnes, K., Biltz, J., Catania, A.,Anti-inflammatory Effects of the Neuropeptide α-MSH in Acute, Chronic and Systemic Inflammation,741 Ann. N.Y. Acad. Sci., 137-148 (1994).
Lipton, J.M., et al.,Anti-inflammatory actions of the Neuroimmunomodulator α-MSH,Immunol. Today 18, 140-145 (1997).
Macaluso, A., McCoy, D., Ceriani, G., Watanabe, T., Biltz, J., Catania, A., and Lipton, J.M.,Antiinflammatory Influences of α-MSH Molecules: Central Neurogenic and Peripheral Actions,14(4), J. of Neuroscience 2377-2382 (1994).
Rajora, N., Boccoli, G., Burns, D., Sharma, S., Catania, A., Lipton, J.M.,α-MSH Modulates Local and Circulating Tumor Necrosis Factor a in Experimental Brain Inflammation,17 J. Neurosci, 2181-2186 (1997).
Rajora, N., Ceriani, G., Catania, A., Star, R.A., Murphy, M.T., Lipton, J.M.,α-MSH production, receptors and influence on neopterin, in a human monocyte/macrophage cell line,59 H. Leukoc. Biol., 248-253 (1996).
Richards, D.B., Lipton, J.M.Effect of α-MSH(11-13) (Lysine-Proline-Valine)on Fever in the Rabbit,5 Peptides, 815-817 (1984).
Richards, Mike, DVM at, <http://www.vetinfo.com/dallergy.html> (Jan. 13, 2001).
Scott, D. W., Miller, W. H., Jr.:Medical Management of Allergic Pruritis in the Cat, with Emphasis on Feline Atopy:J. S. Afr. Vet. Assoc. 64:103: 1993.
Scott, D. W., Miller, W. H., Jr.:Nonsteroidal anti-inflammatory Agents in the Management of Canine Allergic Pruritis:J. S. Afr. Vet. Assoc. 64:52, 1993.
Star, R.A., Rajora, N. Huang, J., Stock, R.C., Catania, A., Lipton, J.M.,Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimultaing hormone,92 Proc. Natl. Acad. Sci., 8016-8020 (1995).
Stevens, D.L.,Could Nonsteroidal Antiinflammatory Drugs(NSAIDs)Enhance in the Progression of Bacterial Infections to Toxic Shock Syndrome?,Clin. Infect. Dis., 21, 977-80 (1997).
Allergy: The most common causes of itching in pets:Cornell University College of Veterinary Medicine Newsletter, Dec. 1999, <http://www.txk9cop.com/allergy.htm>.
Dr. Roen's Weekly Column,at <http://www.roen.com/990913.html>.
U.S. Appl. No. 09/533,341, filed Mar. 23, 2000, Catania Anna P. et al.
U.S. Appl. No. 09/535,066, filed Mar. 23, 2000, Lipton, J.M.
U.S. Appl. No. 60/200,287, filed Apr. 28, 2000, Lipton, J.M.
U.S. Appl. No. 09/774,282, filed Jan. 29, 2001, Lipton, J.M.
Airaghi, L., et. al., “Elevated concentrations of plasma α-MSH are associated with reduced disease progression in HIV-infected patients,” J. Lab. Clin. Med. 133(3) 309-315 (1999).
Airaghi L, Lettino M, Manfredi MG, Lipton JM, Catania A. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am. Heart J. 130: 204-211, 1995.
Airaghi L. Garofalo L. Cutuli MG. Delgado R. Carlin A. Demitri MT. Badalamenti S. Graziani G. Lipton JM. Catania A. Plasma concentrations of α-melanocyte-stimulating hormone are elevated in patients on chronic haemodialysis. Nephrology Dialysis Transplantation 15:1212-1216, 2000.
Baker, M., et. al., “The Relationship between Interleukin-6 and Herpes Simplex Virus Type-I: Implications for Behavior and Immunopathology,”Brain Behav. Immun.13(3):201-11 (1999).
Barker, et al., “Principles of Ambulatory Medicine,”Williams and Wilkins(1982).
Barcellini, W., et al., “Inhibitory Influences of α-MSH peptides on HIV-1 expression in Monocytic cells,” 12thWorld AIDS Conference Geneya, Abstract No. 60685, Jun. 28-Jul. 3, 1998.
Barcellini W, La Maestra L, Clerici G, Garofalo L, Brini AT, Lipton JM, Catania A. α-MSH peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes. Journal of Leukocyte Biology 68:693-699, 2000.
Bhattacharya A., et. al., “Effect of Cyclic AMP on RNA and Protein Synthesis inCandida albicans,” Biochem. Biophysics. Res. Commun.,77: 1438-44 (1977).
Bickers, D., Sun-Induced Disorders,Emergency Medicine Clinics of North America,3(4): 659-663, 660 (1985).
Cartledge, J.D., et. al., “Clinically Significant Azole Cross-Resistance inCandidaIsolates from HIV-Positive Patients with Oral Candidosis,”AIDS11:1839-44 (1997).
Catania, A., et. al., “Melanocortin Peptides Inhibit Production of Proinflammatory Cytokines in Blood of HIV-Infected Patients,”Peptides,19(6): 1099-1104 (1998).
Catania, A.; et. al., “The Neuropeptide α-MSH has Specific Receptors on Neutrophils and Reduces Chemotaxis in Vitro,”Peptides17, 675-679 (1996).
Catania A, Airaghi L, Lipton JM. α-MSH in normal human physiology and disease states. Trends Endocrinol. Metab. 11:304-308, 2000.
Catania A, Delgado R, Airaghi L, Cutuli M, Garofalo L, Carlin A, Demitri MT, Lipton JM. α-MSH in systemic inflammation: central and peripheral actions. Annals of the New York Academy of Sciences, 885:183-187, 1999.
Catania A, Grazia M, Manfredi MG, Airaghi L, Ceriani G, Gandino A, Lipton JM. Cytokine antagonists in infectious and inflammatory disorders. Annals of the New York Academy of
Catania Anna P.
Lipton James M.
Perkins Coie LLP
Snedden Sheridan K
Weber Jon
Zengen, Inc.
LandOfFree
Use of a polypeptide for treatment of pruritis in animals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a polypeptide for treatment of pruritis in animals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a polypeptide for treatment of pruritis in animals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3424071